Martek’s DHA Pricing Stand Based On Long-Term Growth, Fish Oil Competition
This article was originally published in The Tan Sheet
Executive Summary
Martek Biosciences has largely avoided raising prices on its nutritional oil products despite rising material costs because the firm does not want to surrender its competitive advantage in the infant formula and other markets, according to CEO Steve Durbin